Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002

Jemincare Group Has Completed The Phase I Clinical Trial Of Its Anti Sars Cov 2 Neutralizing Antibody Jmb2002

Facebook Comments

Leave a Reply

CommentLuv badge